Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy

Direct-acting antivirals (DAAs) for hepatitis C virus (HCV) may induce hepatitis B virus (HBV) reactivations in co-infected patients, whose dynamics and outcomes could depend on the phase of HBV infection. We investigated HBsAg and HBV-DNA kinetics in fifteen untreated HBeAg Negative Infection (ENI)...

Full description

Bibliographic Details
Main Authors: Piero Colombatto, Elena Palmisano, Gabriele Ricco, Daniela Cavallone, Filippo Oliveri, Barbara Coco, Antonio Salvati, Veronica Romagnoli, Lidia Surace, Marialinda Vatteroni, Mauro Pistello, Agostino Virdis, Ferruccio Bonino, Maurizia Rossana Brunetto
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
hepatitis B virus
hepatitis C virus
co-infection
direct acting antivirals
chronic hepatitis B
HBeAg negative infection
Online Access:https://www.mdpi.com/2077-0383/11/5/1406

Internet

https://www.mdpi.com/2077-0383/11/5/1406

Similar Items